Dunn Isaac B J M D, Power Emma, Casey Liam J, Wootton Bethany M
Discipline of Clinical Psychology, Graduate School of Health, University of Technology, Sydney, NSW, Australia.
Department of Speech Pathology, Graduate School of Health, University of Technology, Sydney, NSW, Australia.
Cogn Behav Ther. 2025 Mar;54(2):246-275. doi: 10.1080/16506073.2024.2434021. Epub 2024 Dec 3.
Internalizing disorders are common in lesbian, gay, bisexual, transgender, queer, questioning, and otherwise non-heterosexual or non-cisgender (LGBTQ+) people. Few studies have evaluated the efficacy of cognitive behavior therapy (CBT), a well-established treatment for internalizing disorders, in LGBTQ+ people. The current study quantitatively synthesized outcomes from existing trials of CBT for internalizing disorders in LGBTQ+ people. Seven databases were searched, identifying 14 relevant studies with a total of 414 participants. A medium within-group effect size was found for depressive symptoms from pre-treatment to post-treatment (k = 14; g = 0.60; 95% CI: 0.44-0.76; I = 71.59) and pre-treatment to 2-6-month follow-up (k = 7; g = 0.63; 95% CI: 0.40-0.86; I = 71.59). For anxiety and related disorder symptoms, a medium within-group effect size was found from both pre-treatment to post-treatment (k = 10; g = 0.73; 95% CI: 0.47-0.99; I = 71.59) and to 3-9-month follow-up (k = 5; g = 0.70; 95% CI: 0.54-0.87; I = 36.04). Exploratory analyses indicated small between-group effects at post-treatment between intervention and control groups. Effect sizes were comparable to those in the general population, indicating preliminary support for treating internalizing disorders in LGBTQ+ people with CBT.
内化性障碍在女同性恋、男同性恋、双性恋、跨性别、酷儿、疑问性取向以及其他非异性恋或非顺性别(LGBTQ+)人群中很常见。很少有研究评估认知行为疗法(CBT)——一种已确立的内化性障碍治疗方法——对LGBTQ+人群的疗效。本研究对现有LGBTQ+人群内化性障碍CBT试验的结果进行了定量综合分析。检索了七个数据库,确定了14项相关研究,共有414名参与者。发现从治疗前到治疗后抑郁症状的组内效应量为中等(k = 14;g = 0.60;95% CI:0.44 - 0.76;I = 71.59),从治疗前到2 - 6个月随访也是如此(k = 7;g = 0.63;95% CI:0.40 - 0.86;I = 71.59)。对于焦虑及相关障碍症状,从治疗前到治疗后(k = 10;g = 0.73;95% CI:0.47 - 0.99;I = 71.59)以及到3 - 9个月随访(k = 5;g = 0.70;95% CI:0.54 - 0.87;I = 36.04)均发现组内效应量为中等。探索性分析表明,干预组和对照组在治疗后组间效应较小。效应量与一般人群相当,表明对用CBT治疗LGBTQ+人群的内化性障碍有初步支持。